Successful outpatient graded administration of trimethoprim-sulfamethoxazole in patients without HIV and with a history of sulfonamide adverse drug reaction

Journal of Allergy and Clinical Immunology: In Practice

Volumn 2, Issue 1, 2014, Pages 52-58

  Pyle, Regan C ^a   Butterfield, Joseph H ^a   Volcheck, Gerald W ^a   Podjasek, Jenna C ^a   Rank, Matthew A ^b   Li, James T C ^a   Harish, Amitha ^c   Poe, Kimberly L ^a   Park, Miguel A ^a  

^a Mayo Clinic College of Medicine   (United States)

^b MAYO CLINIC   (United States)

^c Allergy Associates of New Hampshire   (United States)

Author keywords

Adverse drug reaction; Drug hypersensitivity; Drug intolerance; Graded challenge; Immunologic; Trimethoprim sulfamethoxazole

Indexed keywords

COTRIMOXAZOLE; SULFONAMIDE;

AGED; ARTICLE; CONTROLLED STUDY; DIZZINESS; DOSE RESPONSE; DRUG DOSE ESCALATION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; FEASIBILITY STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALAISE; MALE; NAUSEA; OUTCOME ASSESSMENT; OUTPATIENT; PRURITUS; RASH; RETROSPECTIVE STUDY; SWELLING; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT; URTICARIA; VOMITING;

ADR; ADVERSE DRUG REACTION; DRUG HYPERSENSITIVITY; DRUG INTOLERANCE; GRADED CHALLENGE; IMMUNOLOGIC; ORALLY; PCP; PNEUMOCYSTIS CARINII PNEUMONIA; PO; TMP-SMX; TRIMETHOPRIM-SULFAMETHOXAZOLE;

ADULT; AGED; ALLERGY AND IMMUNOLOGY; AMBULATORY CARE; ANTI-INFECTIVE AGENTS; DESENSITIZATION, IMMUNOLOGIC; DRUG ADMINISTRATION SCHEDULE; DRUG HYPERSENSITIVITY; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 84891656768     PISSN: 22132198     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaip.2013.11.002     Document Type: Article

References (40)

1. Hughes W.T., Kuhn S., Chaundhary S., Feldman S., Verzosa M., Aur R.J., et al. Successful chemoprophylaxis for Pneumocystis carinii pneumonitis. N Engl J Med 1977, 297:1419-1426.
2. Martin M.A., Cox P.H., Beck K., Styer C.M., Beall G.N. A comparison of the effectiveness of three regimens in the prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected patients. Arch Intern Med 1992, 152:523-528.
3. Chung J.B., Armstrong K., Schwartz J.S., Albert D. Cost-effectiveness of prophylaxis against Pneumocystis carinii pneumonia in patients with Wegener's granulomatosis undergoing immunosuppressive therapy. Arthritis Rheum 2000, 43:1841-1848.
4. U.S. Food and Drug Administration. Current Drug Shortages A-D. Available from:. Accessed November 21, 2013. http://www.fda.gov/Drugs/DrugSafety/DrugShortages/ucm314739.htm.
5. Bigby M., Jick S., Jick H., Arndt K. Drug-induced cutaneous reactions. A report from the Boston Collaborative Drug Surveillance Program on 15,438 consecutive inpatients, 1975 to 1982. JAMA 1986, 256:3358-3363.
6. Macy E., Poon K.Y.T. Self-reported antibiotic allergy incidence and prevalence: age and sex effects. Am J Med 2009, 122:778.e1-778.e7.
7. Gruchalla R.S., Pesenko R.D., Do T.T., Skiest D.J. Sulfonamide-induced reactions in desensitized patients with AIDS: the role of covalent protein haptenation by sulfamethoxazole. J Allergy Clin Immunol 1998, 101:371-378.
8. Cortese L.M., Soucy D.M., Endy T.P. Trimethoprim/sulfamethoxazole desensitization. Ann Pharmacother 1996, 30:184-186.
9. Absar N., Daneshvar H., Beall G. Desensitization to trimethoprim/sulfamethoxazole in HIV-infected patients. J Allergy Clin Immunol 1994, 93:1001-1005.
10. Bonfanti P., Pusterla L., Parazzini F., Libanore M., Cagni A.E., Franzetti M., et al. The effectiveness of desensitization versus rechallenge treatment in HIV-positive patients with previous hypersensitivity to TMP-SMX: a randomized multicentric study. C.I.S.A.I. Group. Biomed Pharmacother 2000, 54:45-49.
11. Caumes E., Guermonprez G., Lecomte C., Katlama C., Bricaire F. Efficacy and safety of desensitization with sulfamethoxazole and trimethoprim in 48 previously hypersensitive patients infected with human immunodeficiency virus. Arch Dermatol 1997, 133:465-469.
12. Gluckstein D., Ruskin J. Rapid oral desensitization to trimethoprim-sulfamethoxazole (TMP-SMZ): use in prophylaxis for Pneumocystis carinii pneumonia in patients with AIDS who were previously intolerant to TMP-SMZ. Clin Infect Dis 1995, 20:849-853.
13. Kalanadhabhatta V., Muppidi D., Sahni H., Robles A., Kramer M. Successful oral desensitization to trimethoprim-sulfamethoxazole in acquired immune deficiency syndrome. Ann Allergy Asthma Immunol 1996, 77:394-400.
14. Leoung G.S., Stanford J.F., Giordano M.F., Stein A., Torres R.A., Giffen C.A., et al. Trimethoprim-sulfamethoxazole (TMP-SMZ) dose escalation versus direct rechallenge for Pneumocystis carinii pneumonia prophylaxis in human immunodeficiency virus-infected patients with previous adverse reaction to TMP-SMZ. J Infect Dis 2001, 184:992-997.
15. Nguyen M.T., Weiss P.J., Wallace M.R. Two-day oral desensitization to trimethoprim-sulfamethoxazole in HIV-infected patients. AIDS 1995, 9:573-575.
16. Rich J.D., Sullivan T., Greineder D., Kazanjian P.H. Trimethoprim/sulfamethoxazole incremental dose regimen in human immunodeficiency virus-infected persons. Ann Allergy Asthma Immunol 1997, 79:409-414.
17. Ryan C., Madalon M., Wortham D.W., Graziano F.M. Sulfa hypersensitivity in patients with HIV infection: onset, treatment, critical review of the literature. WMJ 1998, 97:23-27.
18. Straatmann A., Bahia F., Pedral-Sampaio D., Brites C. A randomized, pilot trial comparing full versus escalating dose regimens for the desensitization of AIDS patients allergic to sulfonamides. Braz J Infect Dis 2002, 6:276-280.
19. Yoshizawa S., Yasuoka A., Kikuchi Y., Honda M., Gatanaga H., Tachikawa N., et al. A 5-day course of oral desensitization to trimethoprim/sulfamethoxazole (T/S) in patients with human immunodeficiency virus type-1 infection who were previously intolerant to T/S. Ann Allergy Asthma Immunol 2000, 85:241-244.
20. Moreno J.N., Poblete R.B., Maggio C., Gagnon S., Fischl M.A. Rapid oral desensitization for sulfonamides in patients with the acquired immunodeficiency syndrome. Ann Allergy Asthma Immunol 1995, 74:140-146.
21. White M.V., Haddad Z.H., Brunner E., Sainz C. Desensitization to trimethoprim sulfamethoxazole in patients with acquired immune deficiency syndrome and Pneumocystis carinii pneumonia. Ann Allergy 1989, 62:177-179.
22. Finegold I. Oral desensitization to trimethoprim-sulfamethoxazole in a patient with acquired immunodeficiency syndrome. J Allergy Clin Immunol 1986, 78:905-908.
23. Smith R.M., Iwamoto G.K., Richerson H.B., Flaherty J.P. Trimethoprim-sulfamethoxazole desensitization in the acquired immunodeficiency syndrome. Ann Intern Med 1987, 106:335.
24. Kreuz W., Güngör T., Lotz C., Funk M., Kornhuber B. "Treating through" hypersensitivity to cotrimoxazole in children with HIV infection. Lancet 1990, 336:508-509.
25. Kletzel M., Beck S., Elser J., Shock N., Burks W. Trimethoprim-sulfamethoxazole oral desensitization in hemophiliacs infected with human immunodeficiency virus with a history of hypersensitivity reactions. Am J Dis Child 1991, 145:1428-1429.
26. Carr A., Penny R., Cooper D.A. Efficacy and safety of rechallenge with low-dose trimethoprim-sulphamethoxazole in previously hypersensitive HIV-infected patients. AIDS 1993, 7:65-71.
27. Bachmeyer C., Salmon D., Guerin C., Barre C., Hazebroucq G., Sicard D., Sereni D. Trimethoprim-Sulphamethoxazole desensitization in HIV-Infected patients: an open study. AIDS 1995, 9:299-312.
28. Piketty C., Gilquin J., Kazatchkine M.D. Efficacy and safety of desensitization to Trimethoprim-Sulfamethoxazole in human immunodeficiency virus-infected patients. J Infect Dis 1995, 172:611.
29. Gompels M.M., Simpson N., Snow M., Spickett G., Ong E. Desensitization to co-trimoxazole (trimethoprim-sulphamethoxazole) in HIV-infected patients: is patch testing a useful predictor of reactionα. J Infect 1999, 38:111-115.
30. Hughes T., Almgren J., McGuffin R., Omoto R. Co-trimoxazole desensitization in bone marrow transplantation. Ann Intern Med 1986, 105:148.
31. Mann R., Badesch D., Zamora M., Dreskin S.C. Desensitization to trimethoprim-sulfamethoxazole following lung transplantation. Chest 1997, 111:1147.
32. Soffritti S., Ricci G., Prete A., Rondelli R., Menna G., Pession A. Successful desensitization to trimethoprim-sulfamethoxazole after allogeneic haematopoietic stem cell transplantation: preliminary observations. Med Pediatr Oncol 2003, 40:271-272.
33. Patriarca G., Schiavino D., Buonomo A., Aruanno A., Altomonte G., Nucera E. Desensitization to co-trimoxazole in a patient with fixed drug eruption. J Investig Allergol Clin Immunol 2008, 18:309-311.
34. Nucera E., Schiavino D., Buonomo A., Del Minno M., Sun J., Patriarca G. Tolerance induction to cotrimoxazole. Allergy 2000, 55:681-682.
35. Solensky R., Earl H.S., Gruchalla R.S. Clinical approach to penicillin-allergic patients: a survey. Ann Allergy Asthma Immunol 2000, 84:329-333.
36. Stember R. Prevalence of skin test reactivity in patients with convincing, vague, and unacceptable histories of penicillin allergy. Allergy Asthma Proc 2005, 26:59-64.
37. Jick H. Adverse reactions to trimethoprim-sulfamethoxazole in hospitalized patients. Rev Infect Dis 1982, 4:426-428.
38. Jaffe H.S., Abrams D.I., Ammann A.J., Lewis B.J., Golden J.A. Complications of co-trimoxazole in treatment of AIDS-associated Pneumocystis carinii pneumonia in homosexual men. Lancet 1983, 2:1109-1111.
39. Kennedy C.A., Pimentel J.A., Lewis D.E., Anderson M.D., Weiss P.J., Oldfield E.C. Crossover of human immunodeficiency virus-infected patients from aerosolized pentamidine to trimethoprim-sulfamethoxazole: lack of hematologic toxicity and relationship of side effects to CD4+ lymphocyte count. J Infect Dis 1993, 168:314-317.
40. Joint Task Force on Practice Parameters, American Academy of Allergy, Asthma and Immunology, American College of Allergy, Asthma and Immunology, Joint Council of Allergy, Asthma and Immunology Drug allergy: an updated practice parameter. Ann Allergy Asthma Immunol 2010, 105:259-273.